Recombinant CBD-HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumor

Biochemical and Biophysical Research Communications

Volumn 367, Issue 1, 2008, Pages 144-149

  Gong, Wei ^a   Liu, Yi ^a   Huang, Bo ^a   Lei, Zhang ^a   Wu, Feng Hua ^a   Li, Dong ^a   Feng, Zuo Hua ^a   Zhang, Gui Mei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CBD HepII polypeptide; Fibronectin; Integrin v 3; Tumor metastasis

Indexed keywords

CBD PROTEIN; CH 50; CYCLIN DEPENDENT KINASE; FIBRONECTIN; FOCAL ADHESION KINASE; GELATINASE A; GELATINASE B; HEPII POLYPEPTIDE; PLASMID DNA; POLYPEPTIDE; RECOMBINANT PROTEIN; SYNDECAN 1; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL CYCLE ARREST; CELL STIMULATION; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME MECHANISM; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FEMALE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SURVIVAL TIME; TUMOR BLOOD FLOW; TUMOR CELL; UPREGULATION;

ANIMALS; CDC2 PROTEIN KINASE; CELL ADHESION; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; FIBRINOGEN; FIBRONECTINS; FOCAL ADHESION KINASE 1; GENE THERAPY; INTEGRIN ALPHAVBETA3; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SURVIVAL RATE;

MUS;

EID: 38049074892     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.110     Document Type: Article

References (30)

1. Pilch J., Habermann R., and Felding-Habermann B. Unique ability of integrin alpha(v)beta3 to support tumor cell arrest under dynamic flow conditions. J. Biol. Chem. 277 (2002) 21930-21938
2. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20 (2003) 203-213
3. Nierodzik M.L., Klepfish A., and Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb. Haemost. 74 (1995) 282-290
4. Palumbo J.S., Kombrinck K.W., Drew A.F., Grimes T.S., Kiser J.H., Degen J.L., and Bugge T.H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96 (2000) 3302-3309
5. Akiyama S.K., Olden K., and Yamada K.M. Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev. 14 (1995) 173-189
6. Saito N., Mitsuhashi M., Hayashi T., Narumo C., Nagata H., Soyama K., Kameoka S., Harumiya S., and Fujimoto D. Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470. Int. J. Clin. Oncol. 6 (2001) 215-220
7. Saiki I., Yoneda J., Kobayashi H., Igarashi Y., Komazawa H., Ishizaki Y., Kato I., and Azuma I. Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs. Jpn. J. Cancer Res. 84 (1993) 326-335
8. Yi M., and Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc. Natl. Acad. Sci. USA 98 (2001) 620-624
9. Yoneda J., Saiki I., Kobayashi H., Fujii H., Ishizaki Y., Kato I., Kiso M., Hasegawa A., and Azuma I. Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion. Jpn. J. Cancer Res. 85 (1994) 723-734
10. Kim J., Han I., Kim Y., Kim S., and Oh E.S. C-terminal heparin-binding domain of fibronectin regulates integrin-mediated cell spreading but not the activation of mitogen-activated protein kinase. Biochem. J. 360 (2001) 239-245
11. Huang W., Chiquet-Ehrismann R., Moyano J.V., Garcia-Pardo A., and Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 61 (2001) 8586-8594
12. Zhang G.M., Feng Z.H., Li D., and Zhang H H. Effects of polypeptide CH50 and LPS on macrophage activation and their anti-tumor function. Acta Pharmacol. Sin. 21 (2000) 567-570
13. Zhang G.M., Yang Y., Huang B., Xiao H., Li D., and Feng Z.H. Experimental study on therapeutic effect of expression in vivo of CellI-HepII recombinant polypeptide of fibronectin on murine H22 hepatocellular carcinoma. World J. Gastroenterol. 9 (2003) 1940-1945
14. Liu Y., Huang B., Yuan Y., Gong W., Xiao H., Li D., Yu Z.R., Wu F.H., Zhang G.M., and Feng ZH Z.H. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int. J. Cancer 121 (2007) 184-192
15. Albertine K.H., Cerasoli Jr. F., Gee M.H., Ishihara Y., Tahamont M.V., Gottlieb J.E., and Peters S.P. Morphological analysis of the activation of adherent neutrophils in vitro. Tissue Cell 20 (1988) 519-530
16. He Y.F., Zhang G.M., Wang X.H., Zhang H., Yuan Y., Li D., and Feng Z.H. Blocking programmed death-1 ligand-pd-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J. Immunol. 173 (2004) 4919-4928
17. Pankov R., and Yamada K.M. Fibronectin at glance. J. Cell Sci. 115 (2002) 3861-3863
18. Redick S.D., Settles D.L., Briscoe G., and Erickson H.P. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J. Cell Biol. 149 (2000) 521-527
19. Beauvais D.M., and Rapraeger A.C. Syndecan-1-mediated cell spreading requires signaling by alphavbeta3 integrins in human breast carcinoma cells. Exp. Cell Res. 286 (2003) 219-232
20. Rolli M., Fransvea E., Pilch J., Saven A., and Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 9482-9487
21. Kim S., Harris M., and Varner J.A. Regulation of integrin αvβ3-mediated endothelial cell migration and angiogenesis by integrin α5β1 and protein kinase A. J. Biol. Chem. 275 (2000) 33920-33928
22. Beauvais D.M., Burbach B.J., and Rapraeger A.C. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell Biol. 167 (2004) 171-181
23. Tian B., Li Y., Ji X.N., Chen J., Xue Q., Ye S.L., Liu Y.K., and Tang Z.Y. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J. Cancer Res. Clin. Oncol. 131 (2005) 80-86
24. Bafetti L.M., Young T.N., Itoh Y., and Stack M.S. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 273 (1998) 143-149
25. van Nimwegen M.J., and van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. 73 (2007) 597-609
26. Mitra S.K., and Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 18 (2006) 516-523
27. Manes T., Zheng D.Q., Tognin S., Woodard A.S., Marchisio P.C., and Languino L.R. Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J. Cell Biol. 161 (2003) 817-826
28. Reich R., Blumenthal M., and Liscovitch M. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin. Exp. Metastasis 13 (1995) 134-140
29. Stanton H., Gavrilovic J., Atkinson S.J., d'Ortho M.P., Yamada K.M., Zardi L., and Murphy G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci. 111 (1998) 2789-2798
30. Chambers A.F., and Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Nat. Cancer Inst. 89 (1997) 1260-1270